Category Archives: Hormone Replacement Therapy

Pregnant air travelers face a higher risk of blood clots, but they can reduce their risks by walking airplane aisles, drinking water and doing calf exercises, according to a new review.

For women with additional risk, doctors may recommend compression stockings and injectable blood thinners while traveling, the authors write in the Journal of Travel Medicine.

"Both pregnancy and air travel are risk factors for venous thromboembolism, or a blood clot in the legs or lungs," said senior author Dr Leslie Skeith of the University of Calgary, a member of the CanVECTOR Canadian thrombosis research network.

Blood clots affect about one to two per 1,000 nonpregnant people each year and are the third leading cause of vascular death after heart attacks and strokes, the authors note. With more than two billion passengers flying each year, about 150,000 cases of travel-related blood clots are diagnosed annually.

Long-distance flights tend to increase the risk by three-fold, yet travel-related studies either don't include pregnant women or only include a small number and don't directly investigate how pregnancy increases the risk.

"There is very little evidence to guide what pregnant and postpartum women should do to prevent blood clots while traveling," Skeith said.

Skeith and her colleagues review the many factors that play into an individual's risk for a blood clot, including height, weight, recent surgery, pregnancy, use of oral contraceptives, hormone replacement therapy and a family history of clots or diseases that promote clotting.

With pregnancy in particular, they write, the risk is higher because of physiological changes, such as slower blood flow and blood vessel dilation. Pelvic blood vessels may also be compressed as the uterus grows. Starting in early pregnancy, the body starts to become hypercoagulable, or more likely to form blood clots. These risks remain higher until about 12 weeks after giving birth.

Although the average pregnant or postpartum air traveler faces an increased risk of clots, the absolute risk estimate is low at less than 1%, the study found.

Pregnant women with other risk factors, such as inherited blood problems, obesity and recent surgery, may face a higher blood clot risk, however. Although the risk depends on individual factors, women with a history of blood clots tend to have a 4% higher risk while pregnant, and those with hormonal-associated blood clots tend to have a 6% higher risk while pregnant.

For most women with a history of blood clots, the risk during air travel still remains low at just over 1%. At the same time, pregnant women who face these higher risks should consider using more extensive blood clot prevention measures while traveling, such as the injectable blood thinner low-molecular-weight heparin (LMWH).

"It is known that LMWH prophylaxis lowers the risk of recurrent thrombosis in women with previous venous thromboembolism," said Dr. Ida Martinelli of the University of Milan, who wasn't involved in the study.

However, some studies show that certain blood conditions and blood thinners can lead to complications during delivery, so it's best to consult a doctor for individual recommendations.

Skeith and colleagues are now studying whether aspirin can prevent blood clots in postpartum women with risk factors for clots. The pilot randomized trial, called PARTUM, is expected to start in 2020.

"We desperately need more research to better prevent blood clots in pregnant and postpartum women," Skeith said. "We recommend talking to your doctor about different options."

Read more:
Pregnant women can reduce their blood clot risk on flights - Japan Today

Anew reviewpublished in the Journal of Travel Medicinerecommends simple steps pregnant women can take to reduce their risk of blood clots caused by air travel.

Blood clotting is a part of our natural healing process after an injury. Blood clots can become dangerous, however, according to theAmerican Society of Hematology, when they do not dissolve on their own or they develop inside a blood vessel where there is no apparent injury. When a clot in a vein prevents blood from returning to the heart this can cause pain and swelling.

DVT, or deep vein thrombosis, is a type of clot that develops in a major vein of the body, most often the leg. A pulmonary embolism occurs when the clot spreads through the body to the lungs.

Separately, pregnancy and long-distance flights are both risk factors for blood clots, which means pregnant travelers especially need to be wary.

According to the research byDr. Divya Karsanji of the University of Calgary in Canada and colleagues,the risk of air travel for most pregnant or postpartum women is less than 1%, but that increases when women are faced with other risk factors, like a family history of venous thromboembolism, commonly known as VTE.

The experts say that pregnant women on long flights should take extra precautions, like frequent walks around the cabin, drinking plenty of water and doing calf exercises.

Pregnant women planning to travel by plane who have other VTE risk factors should wear 20-30 mmHg compression stockings and possibly take an injectable blood-thinner.Reutersreported that some studies have linked blood thinners to complications in the delivery room, so pregnant women should consult their doctor.

Other risk factors for blood clots include height, weight, recent surgical procedures, use of an oral contraceptive, hormone replacement therapy and family history.

Dr. Leslie Skeith of the University of Calgary oldReutersthat in 2020 researchers will be conducting a pilot clinical trial investigating whether aspirin can help reduce the risk of blood clots in postpartum women with other VTE risk factors.

"We desperately need more research to better prevent blood clots in pregnant and postpartum women. We recommend talking to your doctor about different options." TheAmerican College of Obstetricians and Gynecologistsadvises that it is generally safe for women to travel until they are 36 weeks pregnant, and the most ideal time to travel is between weeks 14 and 28.

Continued here:
Experts offer tips to help pregnant women traveling by air reduce risk of blood clots - PhillyVoice.com

The X-Men are often cited as a pop culture metaphor for the struggles of persecuted peoples in the face of bigotry. But the allegory is far from perfect. It's barely even present in the foundational DNA of the earliest comics. The idea of "mutants" was initially just an excuse to skip over the origin stories and get straight to the super-powered superhero antics. These days, we commonly hear comparisons between Magneto and Professor X to Malcolm X and MLK. Even though it's, erm, not quite accurate. And even though Magneto started out byliterally calling his team "The Brotherhood of Evil Mutants."

But Bob Proehl's new novel, The Nobody People, takes the opposite approach. Proehl is a friend of mine I even wrote a song to help him promote the book, before I actually I read it and he'll pretty openly admit that he envisioned it as a sort-of love letter to the X-Men. Whereas the X-Men began as pulpy superhero comics that eventually mutated into a political metaphor, The Nobody People starts with the metaphor, and mutates into a powerful personal drama. Here, the super-powered individuals are known as Resonants, and at the start of the novel, their presence is largely hidden from the modern world. The first part of the book mostly follows war correspondent Avi Hirsch, an amputee who learns that his biracial daughter is one of those powered Resonants; once they're outed, the book shifts into a sort of Bildungsroman, with a series of episodes that follow the logical progression of what always happens when a marginalized group tries to claim their own tiny corner in a world full of ignorance of hate. There are friendly Homeland Security agents who still do terrible things; well-intentioned journalists whose cozy relationships with money and power threaten their objectivity; and of course, plenty of powered people, struggling to survive. Moments thatshould be given more emotional heftthe breakups and deaths of beloved characterspass by in a blip of a sentence with no deeper dwelling on the subject, becauseof course these terrible, heartbreaking things happen to persecuted people, andof course the world just keeps moving on without a care.

Nobody People by Thom Dunn

Proehl is much less interested in showing off superpowers than he is in what would happen should a group of super-powered people emerge amidst the social media-fueled vitriol of the Trump era. The book excels not in the fantastical world-building although there is that but rather in his acute observations of the way that different marginalized identities overlap and intersect and fall under different threats in the world. There are Resonants who look like normal wealthy white people, and those privileges cause friction with other characters like Fahima, the queer Muslim woman who also has the ability to speak to machines, or Hayden, a non-binary shape-shifter who relies on their powers as a sort of hormone-replacement therapy. Kay Washington, the wife of the aforementioned war correspondent and mother to a biracial Resonant, is an immigration lawyer who uses her legal skills to argue in favor of the personhood of Resonants whose only crime is being born. Of course, Kay and Avi have to deal with the fact that they used to worry about their daughter non-white appearance, before they realized she'd be under threat for other reasons. There's also a conspiracy theorist media mogul named Jefferson Hargreaves who spews any hateful rhetoric just to help him turn a profit, in a not-so-subtle nod to Alex Jones and InfoWars. Even the main antagonist, Owen Curry, comes off as a frighteningly empathetic school shooter-typehe's violent and terrifying, sure, but you also understand his hatred towards the "Damps" (non-powered people) once you see the way the world has manipulated him.

The Nobody Peopleis the first of a two-book series, with the follow-up,The Somebody People, out in September 2020. As such, the conclusion is, well, hardly conclusive. At some points, it does feel it's already two books in oneAvi Hirsch's journey with his daughterbefore the Resonants go public, and then the aftermath of that, which has a lot more shifting perspectives. But if you want to read a superhero story that cares more about the intimacies of human relationships in a modern socio-political climate than it does about huge epic battle scenes, it's absolutely worth a read.

"The Nobody People" by Bob Proehl [Penguin Random House]

Image via Random House / YouTube

William Gibsons 2014 novel, The Peripheral, is on sale today as a Kindle edition for just . Book description: Flynne Fisher lives down a country road, in a rural America where jobs are scarce, unless you count illegal drug manufacture, which shes trying to avoid. Her brother Burton lives on money from the Veterans Administration, []

George Stephanopoulos asked Stephen King to describe his new (and 61st!) book, The Institute. His answer, Tom Browns Schooldays go to Hell. Sounds like my kind of book, considering Tom Browns schooldays were already pretty awful. Image: Good Morning America/YouTube

Flatland is a novel by Edwin Abbott Abbott, published in 1884. Its written as a biography by A. Square, a two-dimensional creature who is literally a living square, thinner than a sheet of paper. He lives with other two-dimensional creatures on a surface called Flatland. In the book, Mr. Square tells of his adventures in []

So you didnt get all the gifts you wanted this year. Who does? The good news is, theres still time to take advantage of holiday discounts. Here are 10 of our favorite holdovers on holiday deals. Most are already on sale, but you can take an extra 20% off the final price by using the []

Tooth decay is no joke. As dentists are fond of telling you, youve only got one set. (Unless youre, like, 5.) If youre tired of hearing that, maybe its time to minimize those dental visits. This AquaSonic Vibe Toothbrush kit will go a long way toward showing youre serious about your teeth. The brush itself []

CBD (or cannabidiol, if youve been living in a cave) has come a long way in a short while. Its gone from being a relatively unknown, non-psychoactive compound in the hemp plant to a highly-touted stress and pain reliever in just the last few years. You can now get CBD in just about every form: []

See original here:
Review: "The Nobody People" is like a literary X-Men novel for the Trump era - Boing Boing

Study on the Hormone Replacement Therapy Market

The comprehensive report published by Future Market Insights (FMI) offers an in-depth intelligence related to the various factors that are likely to impact the demand, revenue generation, and sales of the Hormone Replacement Therapy Market. In addition, the report singles out the different parameters that are expected to influence the overall dynamics of the Hormone Replacement Therapy Market during the forecast period 2017 2027.

As per the findings of the presented study, the Hormone Replacement Therapy Market is poised to surpass the value of ~US$ XX by the end of 2029 growing at a CAGR of ~XX% over the assessment period 2017 2027. The report includes a thorough analysis of the upstream raw materials, supply-demand ratio of the Hormone Replacement Therapy in different regions, import-export trends and more to provide readers a fair understanding of the global market scenario.

ThisPress Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at https://www.futuremarketinsights.co/reports/sample/REP-GB-3871

The presented study addresses the following queries related to the Hormone Replacement Therapy Market:

The presented market report dives deep into understanding the business strategies adopted by leading market players in the global Hormone Replacement Therapy Market. Further, the SWOT analysis for leading market players is enclosed in the report along with the revenue share, pricing analysis, and product overview of each company.

The extensive study on the Hormone Replacement Therapy Market pinpoints the different factors that are likely to influence the prospects of the Hormone Replacement Therapy Market in each region.

Decisive Information Enclosed in the report:

Get Access To TOC Covering 200+ Topics athttps://www.futuremarketinsights.co/toc/REP-GB-3871

Key Players

Some of the key market players in Global Hormone Replacement Therapy market are Bayer AG, Pfizer, Merck & co., BioSante Pharmaceuticals and Amgen, QuatRx Pharmaceuticals, Noven Pharmaceuticals.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Regional analysis includes

North America (U.S., Canada)

Latin America (Mexico, Brazil and Rest of Latin America)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)

Eastern Europe (Poland, Russia and Rest of Eastern Europe)

Asia Pacific without Japan (China, India, ASEAN, Australia & New Zealand, Rest of Asia Pacific without Japan)

Japan

Middle East and Africa (GCC, S. Africa, and Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint.

NOTE All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Request Customized Report As Per Your Requirements athttps://www.futuremarketinsights.co/customization-available/REP-GB-3871

Why Buy from FMI?

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

T (UK): + 44 (0) 20 7692 8790

This post was originally published on Market Reports Observer

Read more here:
Hormone Replacement Therapy Market Pegged for Robust Expansion During 2017 2027 - Market Reports Observer

Global Hormone Replacement Therapy Market research Report 2019 may be a comprehensive business study on this state of business that analyses innovative ways for business growth and describes necessary factors like prime manufacturers, production worth, key regions and rate of growth. with growth trends, numerous stakeholders like investors, CEOs, traders, suppliers, analysis & media, international Manager, Director, President, SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization and others. This report focuses on Professional Global Hormone Replacement Therapy Market 2019-2025 volume and value at Global level, regional level and company level.

Global Hormone Replacement Therapy Market 2019 report provides key statistics on the market status of the Hormone Replacement Therapy Manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Hormone Replacement Therapy Industry. The Hormone Replacement Therapy industry report firstly announced the Hormone Replacement Therapy Market fundamentals: type applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on.

Request Exclusive Free Sample PDF Of This Report At https://dataintelo.com/request-sample/?reportId=78427

Hormone Replacement Therapy market competition by top manufacturers/ Key player Profiled:F. Hoffmann-La RocheNovartisNovo NordiskAmgenANI PharmaceuticalsBayerEli LillyHisamitsu PharmaceuticalIpsenMerckMylan LaboratoriesOrionQuatRx PharmaceuticalsTeva Pharmaceutical IndustriesTherapeuticsMDAnd More

Hormone Replacement Therapy Market is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2025, from xx million US$ in 2019, according to a new study.

Hormone Replacement Therapy Market Segment by Type covers:Estrogen Replacement TherapyGrowth Hormone Replacement Therapy

Hormone Replacement Therapy Market Segment by Applications can be divided into:MenopauseHypothyroidismMale HypogonadismGrowth Hormone Deficiency

Regional analysis covers:North America (USA, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, Columbia etc.)Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

This report focuses on the Hormone Replacement Therapy in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

For More Information on this report, Request Inquiry At https://dataintelo.com/enquiry-before-buying/?reportId=78427

Key questions answered in the report:What will the market growth rate of Hormone Replacement Therapy market?What are the key factors driving the Global Hormone Replacement Therapy market?Who are the key manufacturers in Hormone Replacement Therapy market space?What are the market opportunities, market risk and market overview of the Hormone Replacement Therapy market?What are sales, revenue, and price analysis of top manufacturers of Hormone Replacement Therapy market?Who are the distributors, traders and dealers of Hormone Replacement Therapy market?What are the Hormone Replacement Therapy market opportunities and threats faced by the vendors in the Global Hormone Replacement Therapy industries?What are sales, revenue, and price analysis by types and applications of Hormone Replacement Therapy market?What are sales, revenue, and price analysis by regions of Hormone Replacement Therapy industries?

Key Benefits Major countries in each region are mapped according to individual market revenue. Comprehensive analysis of factors that drive and restrict the market growth is provided. The report includes an in-depth analysis of current research and clinical developments within the market. Key players and their key developments in the recent years are listed.And More.

The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Hormone Replacement Therapy market in 2025 is also explained. Additionally, type wise and application wise consumption tables and figures of Hormone Replacement Therapy market are also given.

To Buy this Report, Visit https://dataintelo.com/checkout/?reportId=78427

Objective of Studies: To provide strategic profiling of key players in the market, comprehensively analysing their core competencies, and drawing a competitive landscape for the market. To provide insights about factors affecting the market growth. To analyse the Hormone Replacement Therapy market based on various factors- price analysis, supply chain analysis, porter five force analysis etc. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Hormone Replacement Therapy market. To provide country level analysis of the market with respect to the current market size and future prospective. To provide country level analysis of the market for segment by application, product type and sub-segments. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World. To track and analyse competitive developments such as joint ventures, strategic alliances, new product developments, and research and developments in the Global Hormone Replacement Therapy market.

For Best Discount on purchasing this report, Visit https://dataintelo.com/ask-for-discount/?reportId=78427

About DataIntelo:DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info DataInteloName Alex MathewsEmail [emailprotected]Website https://dataintelo.comAddress 500 East E Street, Ontario, CA 91764, United States.

This post was originally published on Market Research Sheets

Originally posted here:
Hormone Replacement Therapy Market Global Sales, Revenue, Price and Gross Margin Forecast To 2025 - Market Research Sheets

Lorraine Kelly has helped ITV to become a dominant player in the daytime television space, since joining the channel back in 1993. Her enduring appeal has culminated in her landing her own show, the eponymous Lorraine, which sees her interview celebrities and cover lifestyle trends in her characteristically bright and bubbly tone. The presenter may project a positive energy in front of the camera, but she has struggled with symptoms associated with a common health condition behind it.

In an extract from her book Shine obtained by Scotsman.com, she spoke of about her battle with the menopause, revealing how the symptoms were overwhelming at times.

Lorraine admitted it was her husband Steve who urged her to seek professional help after noticing it was having a detrimental effect on her wellbeing.

She said: The menopause crept up on me, to be honest. It probably started when I was around 54 and it got gradually worse and worse, until one day it was unbearable.

I just wasnt coping or enjoying life and was constantly knackered, but I simply couldnt understand why.

READ MORE:Emma Bunton health: It nearly broke me Singers shocking health diagnosis

The presenter opened up about the moment she knew something wasnt right: The turning point came on a weekend away with Steve in Spain, which should have been amazing but, like everything else at that time, I just couldnt enjoy it.

Lorraine consulted TVs Dr Hilary Jones the next day about her symptoms, who confirmed her symptoms were the result of the menopause.

What is the menopause?

According to the NHS, the menopause is a natural part of the ageing process when a woman stops having periods and is no longer able to get pregnant naturally.

Periods usually start to become less frequent over a few months or years before they stop altogether. Sometimes they can stop suddenly, explained the health body.

DON'T MISSPaul Hollywood health: Great British Bake Off stars secret battle - the symptoms[INSIGHT]Trisha Goddard health: I was overwhelmed Dancing On Ice star on diagnosis of condition[INSIGHT]Mikey North health: Its horrendous Actors unusual sleep condition[INSIGHT]

As the NHS explains, most women will experience menopausal symptoms and some of these symptoms can be quite severe and have a significant impact on your everyday activities.

Common symptoms include:

Menopausal symptoms can begin months or even years before your periods stop and last around four years after your last period, although some women experience them for much longer, explained the NHS.

It's worth talking to a GP if you have menopausal symptoms that are causing you grief or if you're experiencing symptoms of the menopause before 45 years of age, advises the NHS.

They can usually confirm whether you're menopausal based on your symptoms, but a blood test to measure your hormone levels may be carried out if you're under 45, said the health site.

Your GP can offer treatments and suggest lifestyle changes if you have severe menopausal symptoms that interfere with your day-to-day life.

These include:

Hormone replacement therapy (HRT) tablets, skin patches, gels and implants that relieve menopausal symptoms by replacing oestrogen

Hormonal replacement therapy, which replaces hormones that are at a lower level as you approach the menopause, does come with certain risks, however.

As the NHS notes, some types of HRT can increase your risk of breast cancer, although the benefits of HRT are generally believed to outweigh the risks.

The menopause is caused by a change in the balance of the body's sex hormones, which occurs as you get older, explained the NHS.

It happens when your ovaries stop producing as much of the hormone oestrogen and no longer release an egg each month, explains the health site.

It added: Sometimes it's caused by a treatment such as surgery to remove the ovaries (oophorectomy), some breast cancer treatments, chemotherapy or radiotherapy, or it can be brought on by an underlying medical condition, such as Down's syndrome or Addison's disease.

Read the original post:
Lorraine Kelly health: ITV host reveals health condition that left her knackered' - Express

Coherent Market Research adds Hormone Replacement Therapy Market Report provides an analytical assessment of the prime challenges faced by this Market currently and in the coming years, which helps Market participants in understanding the problems.

The Hormone Replacement Therapy Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on a global and regional level. This report studies the global Hormone Replacement Therapy Market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Hormone Replacement Therapy Market by companies, region, type, and end-use industry.

Hormone Replacement Therapy Market Report covers the following major players: Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company.

Get Free Request Sample from Industry Experts @ https://www.coherentmarketinsights.com/insight/request-sample/2079

This Hormone Replacement Therapy market research study is a collection of insights that translate into a gist of this industry. It is explained in terms of a plethora of factors, some of which include the present scenario of this marketplace in tandem with the industry scenario over the forecast timespan.

The report is also inclusive of some of the major development trends that characterize the Hormone Replacement Therapy market. A comprehensive document in itself, the Hormone Replacement Therapy market research study also contains numerous other pointers such as the current industry policies in conjunction with the topographical industry layout characteristics. Also, the Hormone Replacement Therapy market study is comprised of parameters such as the impact of the current market scenario on investors.

Promising Regions & Countries Mentioned In The Hormone Replacement Therapy Market Report:

Get Free PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2079

Regional landscape:

How will the details provided in the report help prominent stakeholders?

The information that this study delivers, pertaining to the geographical landscape, is indeed rather vital.

As per the study, the topographical spectrum of this industry covers the geographies of North America, Europe, Asia-Pacific & Middle East and Africa.

The study, in detail, enumerates the overview of the regional scope with respect to the growth rate that is likely to be recorded by each region over the projected duration.

Other important aspects pertaining to the topographical reach that may prove important for buyers include the remuneration and the production volume with regards to each region. The market share which every region holds in the industry has also been provided.

Get Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2079

If you wish to want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

This post was originally published on Market Research Sheets

View post:
Hormone Replacement Therapy Market Analysis by Companies, Regions and Growth Forecast 2019 2027 - Market Research Sheets

Radiographers are responsible for taking MRI scans.

BBC News reports on a new large-scale trial that will test if MRI scans could be used to screen men for prostate cancer. The trial will invite 300 randomly selected men aged 50 to 75 years old to have a 10-minute MRI scan and a PSA blood test. Scientists are hoping to find out if using MRI in this way could help to flag men who have signs of prostate cancer without the need for a biopsy. Weve blogged before about how scientists are working to improve prostate cancer diagnosis.

A British woman is the first person in the world to receive a new treatment that aims to deliver high doses of chemotherapy directly to cancer cells. The treatment, which uses tiny clusters of bubbles and liquid droplets to enhance the delivery of chemotherapy, is part of a clinical trial being carried out in London thats looking to reduce the number of doses of chemotherapy and its side effects for cancer patients. Read the full story in The Metro.

A cheaper version of the breast cancer drug Herceptin has been approved by the World Health Organisation (WHO). This decision will make it possible for women in low-income countries to benefit from treatment. This type of hormone therapy blocks off certain cancers fuel supply. More on this in The Guardian.

Several Facebook groups promoting a dangerous skin cancer treatment have been banned from the social media channel, following concerns about sensational health claims. Groups were promoting a black salve paste, which they claimed had the ability to cure skin cancer by eating away at only cancerous cells. According to Buzzfeed News, the groups have been found to be in violation of Facebook rules that prohibit violent and criminal behaviour. Commenting on the story, experts strongly advised anyone considering taking an alternative or complimentary medicine to seek advice from a trained medical professional.

The Mail Online covers a study that says that post-menopausal women who are overweight could reduce their risk of breast cancer if they lose at least 20lbs. But the results present quite a complicated picture. Women who had sustainedweightloss only had a reduced cancer risk if they werent taking hormone replacement therapy (HRT). And because hormone replacement therapy can increase the risk of breast cancer too, its hard to untangle which risk factor is having an effect. Unfortunately, theres still not enough evidence to know what effect different patterns ofweightloss can have on cancer risk.

Scarlett Sangster is a writer for PA Media Group

More on this topic

View original post here:
News digest prostate cancer MRI trial, drug delivery, cancer cures on Facebook and weight loss - Cancer Research UK - Science Blog

Coherent Market Research adds Hormone Replacement Therapy Market Report provides an analytical assessment of the prime challenges faced by this Market currently and in the coming years, which helps Market participants in understanding the problems.

The Hormone Replacement Therapy Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on a global and regional level. This report studies the global Hormone Replacement Therapy Market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Hormone Replacement Therapy Market by companies, region, type, and end-use industry.

Hormone Replacement Therapy Market Report covers the following major players: Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company.

Get Free Request Sample from Industry Experts @ https://www.coherentmarketinsights.com/insight/request-sample/2079

This Hormone Replacement Therapy market research study is a collection of insights that translate into a gist of this industry. It is explained in terms of a plethora of factors, some of which include the present scenario of this marketplace in tandem with the industry scenario over the forecast timespan.

The report is also inclusive of some of the major development trends that characterize the Hormone Replacement Therapy market. A comprehensive document in itself, the Hormone Replacement Therapy market research study also contains numerous other pointers such as the current industry policies in conjunction with the topographical industry layout characteristics. Also, the Hormone Replacement Therapy market study is comprised of parameters such as the impact of the current market scenario on investors.

Promising Regions & Countries Mentioned In The Hormone Replacement Therapy Market Report:

Get Free PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2079

Regional landscape:

How will the details provided in the report help prominent stakeholders?

The information that this study delivers, pertaining to the geographical landscape, is indeed rather vital.

As per the study, the topographical spectrum of this industry covers the geographies of North America, Europe, Asia-Pacific & Middle East and Africa.

The study, in detail, enumerates the overview of the regional scope with respect to the growth rate that is likely to be recorded by each region over the projected duration.

Other important aspects pertaining to the topographical reach that may prove important for buyers include the remuneration and the production volume with regards to each region. The market share which every region holds in the industry has also been provided.

Get Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2079

If you wish to want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

This post was originally published on Market Research Sheets

Go here to see the original:
Hormone Replacement Therapy Market Share Value Projected to Expand by 2019 2027 - Market Research Sheets

Throughout her every transformation, be it musical or visual, Sinad OConnor has remained instantly recognisable irreducibly herself. Wrapped in a black PVC mini-dress and sporting a bobbed wig on the cover of her last album, Im Not Bossy, Im The Boss (a long-ago 2014), the Irish singer was still identifiable as the shaven-headed young woman from the all-conquering Nothing Compares 2 U video, and as the pop star who tore up a picture of the pope on live US television in 1992.

A few days after her 53rd birthday, taking the stage on the only mainland UK date of her current tour, OConnor is barefoot, clad in a black abaya with a subtle geometric check, and wearing a hijab still unmistakable, despite a change in religion, two changes of name, some assertions of non-binary sexuality and a three-and-a-half-year process of regaining good mental health. Just as the Cassandra of Greek myth was doomed to tell the truth and not be believed, OConnors 1992 declarations about abuse in the Catholic church are now a very public scandal.

She is undergoing an act of renewal. Last year, she released a demo of new music under the name Magda Arjuna Davitt, expressing a desire to rid herself of her patriarchal slave name and parental curses. Now she goes by the name Shuhada Sadaqat (Shuhada is an Arabic girls name; sadaqat refers to a voluntary sign of faith).

Throughout, OConnor is a picture of restraint She still hits plenty of high notes, but she does it when it suits her

Even more striking than her shape-shifting constancy, perhaps, is the unwavering quality of her voice, which remains imbued with moral authority and the kind of tell-tale timbre that requires nanoseconds to recognise.

When OConnor she continues to use this name for work opens her mouth tonight to sing Queen of Denmark, a John Grant song that she has made her own, her voice still goes from nought-to-righteous ire in one breath. Why dont you take it out on somebody else? she hollers, to wild hoots of approval.

Throughout this often mesmerising gig, OConnor is a picture of restraint under-singing not because she has to, but because she is a master stylist. She still hits plenty of high notes, but she does it when it suits her. Also wonderfully unchanged is the way OConnor emphatically yanks her chin to one side on a crescendo, as though the full blare of her voice might overpower the microphone.

This tour which goes by the gnomic name 786 began with rave reviews in Ireland; it is set to continue, in bursts, well into 2020 as OConnor comes back into the world. Her timing has a little kismet about it. Uncompromising young women are no longer universally vilified, as OConnor was in the 90s. For all the abuse Greta Thunberg receives, her message and its unsmiling delivery resonates widely.

Most of OConnors compositions are love songs, but her political songs are now, once again, very relevant. Last summer, the US guitarist Sharon Van Etten revived one of OConnors old tunes, Black Boys on Mopeds. OConnors version goes down very well tonight. These are dangerous days, it goes (its set in the Thatcher era), and there are howls from the crowd, many of whom remember the last stretch of Tory hegemony first-hand.

Perhaps most germane to the present moment is OConnors very open, public and ongoing conversation about her physical and mental health. In 2017, she told a US television talk show that a hysterectomy in 2015 plunged her into full menopause, and OConnor cites the lack of hormone replacement therapy post-op as contributing to a suicide attempt.

That same year, the singer posted a distressed and distressing video from a New Jersey motel room. In the months that followed, she received in-patient therapy. She told the Irish broadcaster Dave Fanning last June that if I hadnt been in hospital for three and a half years I wouldnt be alive to sit here talking. She described therapeutic work undertaken on the trauma she sustained in childhood (her mother was a violent alcoholic who died when OConnor was 18) and the difficulty doctors had in arriving at her precise diagnosis.

Anyone following OConnors Twitter account lately will know she recently gave up smoking, broke a lumbar vertebra and is now selling her motorbike as a result. Happily, she is now also officially 99.999999% debt-free. There is new management two of her former bandmates and a memoir with a US publisher set to come out sometime after the US election, written in the style of a blog. There is talk also of not one, but two new albums. One looks set to be cover versions; the other might be called No Mud No Lotus, after the Buddhist idea that something of value comes out of suffering. Or it might be called AKA, given the frequent name changes.

Although every song OConnor serves up tonight emphatically has something to say, there are times when you do question the medium in which they are delivered. It is high time OConnor made a record that didnt have the foursquare thump of pop-rock at its heart her voice and her writing deserve something braver, more beautiful.

Backing her on this tour is a perfectly fine band of players beanpole electric guitarist Phil Edgar and sweet-voiced acoustic guitarist Jackie Rainey combine to sing harmonies with OConnor on In This Heart but the plodding metre feels dated, especially given the endless artistic possibilities of OConnors transcendental voice.

Harbour, from 2014, shows what she can do with a faintly jazzy blues. When she performs a cappella, however, time stands still. I Am Stretched on Your Grave is a traditional song OConnor recorded for I Do Not Want What I Havent Got (1990). Tonights version raises the hairs on your gooseflesh, with OConnors spectral voice soaring, and her intonation suggesting everything from traditional Celtic music to Arabic devotionals.

In 2015, OConnor retired Nothing Compares 2 U from her live repertoire, saying she didnt emotionally relate to the song any more. Its back, with new melismas and missing absolutely none of its heartbroken power. Even more shivery, however, is the moment in the encore, when OConnor starts her newest song, Milestones, without accompaniment and with the microphone switched off. Gradually, her voice rises and the amplification is turned back on. Evil is not my true nature, she sings. For a few pregnant seconds, this busy venue is in rapt silence.

Go here to see the original:
Sinad OConnor review still nothing compares - The Guardian